publication date: Feb. 21, 2014


By Matthew Bin Han Ong

Victor Dzau, chancellor of health affairs at Duke University and president and CEO of the Duke University Health System, was named president of the Institute of Medicine.

Dzau will succeed current IOM president Harvey Fineberg effective July 1.

Dzau has served as an advisor to universities, corporations, and foreign governments, and is a member of the Board of Health Governors and chair of the Global Agenda Council on Personalized and Precision Medicine for the World Economic Forum.

“I recognize the critically important role that the IOM will have in improving the health of the nation at a time of extraordinary evolution in biomedical research and health care delivery,” Dzau said in a statement. “The explosion of new data resources, novel technologies and breathtaking research advances make this the most promising time in history for driving innovations that will improve health care delivery, outcomes and quality.”

In his nearly 10 years at Duke, Dzau spearheaded the creation of the Duke–National University of Singapore Graduate Medical School, as well as the Duke Global Health Institute, the Duke Institute for Health Innovation, the Duke Cancer Institute, and the Duke Translational Medicine Institute.

Under his leadership, the university’s health system has undergone a transformation of its clinical information systems into a single electronic health record. Dzau also led a transformation of the Duke Medicine campus that has added the new Duke Cancer Center facility, the Duke Medicine Pavilion, the Trent Semans Center for Health Education, a new Duke University School of Nursing facility, and … Continue reading 40-08 Duke’s Victor Dzau Named IOM President

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.